HCV-TEST
European patent · EP1546414 · Deleted
Register entry
- Publication number
- EP1546414
- Application number
- EP03755795
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- Deleted
- Specification
- Granted
- Filed
- Sep 8, 2003
- Published
- Jun 29, 2005
- Granted
- Oct 8, 2008
- Deleted
- Apr 27, 2023
- Reason
- Annual fee unpaid
- IPC classes
- G01N 33/576 (2006.01)G01N 33/569 (2006.01)G01N 33/543 (2006.01)C12Q 1/70 (2006.01)
- Priority
- US 409515 P 09.09.2002
- PCT application
- PCT/US2003/028071 08.09.2003
- PCT publication
- WO2004/021871 18.03.2004
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Apr 27, 2023
Deleted, fee unpaid
Published in Swissreg on 27.04.2023
- Sep 22, 2021
Agent removed
- Representative
- Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich (removed)
Published in Swissreg on 22.09.2021
- Aug 26, 2016
Transferred
- Owner
- Novartis Vaccines and Diagnostics, Inc., 4560 Horton Street, Emeryville, CA 94608, USA → Grifols Worldwide Operations Limited, Grange Castle Business Park, Grange Castle, Clondalkin, Dublin 22, Ireland
Published in Swissreg on 26.08.2016
- Aug 24, 2016
Agent entered
- Representative
- Isler & Pedrazzini AG, Postfach 1772, 8027 Zürich
Published in Swissreg on 24.08.2016
- Jan 6, 2009
Agent entered
- Representative
- Patentanwälte, Schaad, Balass, Menzl & Partner AG, Dufourstrasse 101, 8034 Zürich
Published in Swissreg on 06.01.2009
- Oct 8, 2008
Granted
Published in Swissreg on 08.10.2008
Parties
Inventor
ARCANGEL, Phillip
Oakland, CA 94611, US
CHIEN, David
Alamo, CA 94507, US
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.